MYC in Regulating Immunity: Metabolism and Beyond

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2017 Mar 2

PMID 28245597

Citations 50

Authors

J N Rashida Gnanaprakasam

Ruoning Wang

Affiliations

Soon will be listed here.

Abstract

Myelocytomatosis oncogene (MYC) family members, including cellular MYC (c-Myc), neuroblastoma derived MYC (MYCN), and lung carcinoma derived MYC (MYCL), have all been implicated as key oncogenic drivers in a broad range of human cancers. Beyond cancer, MYC plays an important role in other physiological and pathological processes, namely immunity and immunological diseases. MYC largely functions as a transcription factor that promotes the expression of numerous target genes to coordinate death, proliferation, and metabolism at the cellular, tissue, and organismal levels. It has been shown that the expression of MYC family members is tightly regulated in immune cells during development or upon immune stimulations. Emerging evidence suggests that MYC family members play essential roles in regulating the development, differentiation and activation of immune cells. Through driving the expression of a broad range of metabolic genes in immune cells, MYC family members coordinate metabolic programs to support immune functions. Here, we discuss our understanding of MYC biology in immune system and how modulation of MYC impacts immune metabolism and responses.

Citing Articles

Discovering root causal genes with high-throughput perturbations.

Strobl E, Gamazon E Elife. 2025; 13.

PMID: 40042510 PMC: 11882141. DOI: 10.7554/eLife.100949.

Food for thought: Nutrient metabolism controlling early T cell development.

Werlen G, Hernandez T, Jacinto E Bioessays. 2024; 47(1):e2400179.

PMID: 39504233 PMC: 11662157. DOI: 10.1002/bies.202400179.

How lactate affects immune strategies in lymphoma.

Zhou Y, Lou J, Tian Y, Ding J, Wang X, Tang B Front Mol Biosci. 2024; 11:1480884.

PMID: 39464313 PMC: 11502318. DOI: 10.3389/fmolb.2024.1480884.

Acidity suppresses CD8 + T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling.

Vuillefroy de Silly R, Pericou L, Seijo B, Crespo I, Irving M EMBO J. 2024; 43(21):4922-4953.

PMID: 39284912 PMC: 11535206. DOI: 10.1038/s44318-024-00235-w.

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer.

Casacuberta-Serra S, Gonzalez-Larreategui I, Capitan-Leo D, Soucek L Signal Transduct Target Ther. 2024; 9(1):205.

PMID: 39164274 PMC: 11336233. DOI: 10.1038/s41392-024-01907-z.

References

Lin C, Loven J, Rahl P, Paranal R, Burge C, Bradner J . Transcriptional amplification in tumor cells with elevated c-Myc. Cell. 2012; 151(1):56-67. PMC: 3462372. DOI: 10.1016/j.cell.2012.08.026. View

Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W . c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell. 2012; 151(1):68-79. PMC: 3471363. DOI: 10.1016/j.cell.2012.08.033. View

Grandori C, Cowley S, James L, Eisenman R . The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol. 2000; 16:653-99. DOI: 10.1146/annurev.cellbio.16.1.653. View

Pelengaris S, Khan M, Evan G . c-MYC: more than just a matter of life and death. Nat Rev Cancer. 2002; 2(10):764-76. DOI: 10.1038/nrc904. View

Dang E, Barbi J, Yang H, Jinasena D, Yu H, Zheng Y . Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011; 146(5):772-84. PMC: 3387678. DOI: 10.1016/j.cell.2011.07.033. View

Galvan-Pena S, ONeill L . Metabolic reprograming in macrophage polarization. Front Immunol. 2014; 5:420. PMC: 4151090. DOI: 10.3389/fimmu.2014.00420. View

Palazon A, Goldrath A, Nizet V, Johnson R . HIF transcription factors, inflammation, and immunity. Immunity. 2014; 41(4):518-28. PMC: 4346319. DOI: 10.1016/j.immuni.2014.09.008. View

Grumont R, Lock P, Mollinari M, Shannon F, Moore A, Gerondakis S . The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-kappaB-dependent c-myc expression. Immunity. 2004; 21(1):19-30. DOI: 10.1016/j.immuni.2004.06.004. View

Wang R, Green D . The immune diet: meeting the metabolic demands of lymphocyte activation. F1000 Biol Rep. 2012; 4:9. PMC: 3342832. DOI: 10.3410/B4-9. View

10.

Krawczyk C, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis R . Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010; 115(23):4742-9. PMC: 2890190. DOI: 10.1182/blood-2009-10-249540. View

11.

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

12.

Roussel M, Cleveland J, Shurtleff S, Sherr C . Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature. 1991; 353(6342):361-3. DOI: 10.1038/353361a0. View

13.

Nesbit C, Tersak J, Prochownik E . MYC oncogenes and human neoplastic disease. Oncogene. 1999; 18(19):3004-16. DOI: 10.1038/sj.onc.1202746. View

14.

Vadiveloo P . Macrophages--proliferation, activation, and cell cycle proteins. J Leukoc Biol. 1999; 66(4):579-82. DOI: 10.1002/jlb.66.4.579. View

15.

Zhu J, Paul W . Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010; 238(1):247-62. PMC: 2975272. DOI: 10.1111/j.1600-065X.2010.00951.x. View

16.

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

17.

Kohl N, Kanda N, Schreck R, Bruns G, LATT S, Gilbert F . Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell. 1983; 35(2 Pt 1):359-67. DOI: 10.1016/0092-8674(83)90169-1. View

18.

Haschemi A, Kosma P, Gille L, Evans C, Burant C, Starkl P . The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 2012; 15(6):813-26. PMC: 3370649. DOI: 10.1016/j.cmet.2012.04.023. View

19.

von Andrian U, Mackay C . T-cell function and migration. Two sides of the same coin. N Engl J Med. 2000; 343(14):1020-34. DOI: 10.1056/NEJM200010053431407. View

20.

Igarashi K, Kashiwagi K . Modulation of cellular function by polyamines. Int J Biochem Cell Biol. 2009; 42(1):39-51. DOI: 10.1016/j.biocel.2009.07.009. View